— Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit of $18.9 million last year.
— Loss per share was $0.14, compared to earnings of $0.12 per share in the year-ago period
— Fourth-quarter net revenues surged to $16.3 million from $3.2 million last year
— Gross margin, before fair value changes to biological assets and inventories, dropped to $0.7 million from $1.6 million last year
— Adjusted EBITDA was (-)$7.9 million during the three-month period, compared $0.3 million a year earlier
— In the first quarter of 2020, net revenue is expected to increase sequentially on higher retail sales and wholesale revenue
— First-quarter gross margin, before fair value changes to biological assets and inventories, is anticipated to grow sequentially
— Expects the increased efficiencies and economies of scale to reduce cultivation costs in the first quarter, compared to Q4
Most Popular
These fast-food stocks can strengthen your portfolio this year. Here’s why
For American restaurant chains, the early months of the pandemic were a challenging period. But soon things changed for the better as people started ordering their favorite food items online
What to expect when McCormick & Company (MKC) reports Q1 results next week
Shares of McCormick & Company, Incorporated (NYSE: MKC) were up over 2% on Friday. The stock has dropped 12% year-to-date. The condiments manufacturer is scheduled to report its first quarter 2023
KB Home (KBH) Earnings: 1Q23 Key Numbers
KB Home (NYSE: KBH) reported total revenues of $1.38 billion for the first quarter of 2023 which was relatively flat compared to the same period last year. Net income of
Comments
Comments are closed.